CPHI 2026 recently wrapped up. Fumei showcased ultra-refined pharmaceutical excipients and highlighted four decades of expertise in waxes, lipids, and derivatives.
Fumei manufactures pharmaceutical-grade petrolatum at its EXCiPACT-certified facility. Meeting ChP, EP, and USP standards, the high-viscosity grade undergoes multi-stage purification to eliminate polycyclic aromatic hydrocarbons and heavy metals. Purity exceeds 99.9%, while microbial and ignition residue levels remain tighter than typical industry benchmarks.
Fumei’s ultra-pure petrolatum provides strong film-forming and moisture-locking properties, serving as an oily base for ointments, eye ointments, and transdermal patches. It extends drug release, maintains viscosity stability, and prevents stratification and seepage. It is also used in topical skin preparations, wound dressings, and medical device lubrication.
Localized production offers domestic pharmaceutical companies a reliable, cost-effective raw material source. Also Fumei’s fatty alcohol and glyceride series function as emulsifiers, thickeners, and stabilizers for pharmaceutical formulations. Fumei plans to expand its excipient portfolio and deepen technical collaboration with pharmaceutical partners worldwide.
